Literature DB >> 8995703

Rhodanine resistance and dependence of echovirus 12: a possible consequence of capsid flexibility.

W Kraus1, H Zimmermann, H J Eggers, B Nelsen-Salz.   

Abstract

Recombinant viruses of echovirus 12 carrying mutations of a rhodanine-resistant or -dependent variant, were investigated, and five single mutations each inducing a rhodanine-resistant or -dependent phenotype were defined. Four mutations are localized in the capsid protein VP1, and the fifth exchange is in VP4. All original and recombinant viruses were shown to be stabilized by the antiviral drug rhodanine against heat inactivation. Hence, resistant and dependent variants still seem able to bind rhodanine, and apparently none of the exchanges affects the putative drug binding site. We hypothesize that drug resistance and dependence are consequences of an increased flexibility of the virus capsid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995703      PMCID: PMC191234     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Selective inhibiton of uncoating of echovirus 12 by rhodanine. A study on early virus-cell interactions.

Authors:  H J Eggers
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

2.  Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.

Authors:  J Badger; I Minor; M J Kremer; M A Oliveira; T J Smith; J P Griffith; D M Guerin; S Krishnaswamy; M Luo; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Infectious cDNA clones of echovirus 12 and a variant resistant against the uncoating inhibitor rhodanine differ in seven amino acids.

Authors:  W Kraus; H Zimmermann; A Zimmermann; H J Eggers; B Nelsen-Salz
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

4.  Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution.

Authors:  R Basavappa; R Syed; O Flore; J P Icenogle; D J Filman; J M Hogle
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

5.  Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.

Authors:  A G Mosser; J Y Sgro; R R Rueckert
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors.

Authors:  D C Pevear; M J Fancher; P J Felock; M G Rossmann; M S Miller; G Diana; A M Treasurywala; M A McKinlay; F J Dutko
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

Review 7.  Poliovirus: new insights from an old paradigm.

Authors:  M W Wien; M Chow; J M Hogle
Journal:  Structure       Date:  1996-07-15       Impact factor: 5.006

8.  Foot-and-mouth disease virus particles contain replicase protein 3D.

Authors:  J F Newman; P G Piatti; B M Gorman; T G Burrage; M D Ryan; M Flint; F Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

9.  Rhodanine: a selective inhibitor of the multiplication of echovirus 12.

Authors:  H J Eggers; M A Koch; A Furst; G D Daves; J J Wilczynski; K Folkers
Journal:  Science       Date:  1970-01-16       Impact factor: 47.728

10.  Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.

Authors:  R A Grant; C N Hiremath; D J Filman; R Syed; K Andries; J M Hogle
Journal:  Curr Biol       Date:  1994-09-01       Impact factor: 10.834

View more
  3 in total

1.  Fatty acid-depleted albumin induces the formation of echovirus A particles.

Authors:  T Ward; R M Powell; Y Chaudhry; J Meredith; J W Almond; W Kraus; B Nelsen-Salz; H J Eggers; D J Evans
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives.

Authors:  H Shimizu; M Agoh; Y Agoh; H Yoshida; K Yoshii; T Yoneyama; A Hagiwara; T Miyamura
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species.

Authors:  Kristina Lanko; Liang Sun; Mathy Froeyen; Pieter Leyssen; Leen Delang; Carmen Mirabelli; Johan Neyts
Journal:  Antiviral Res       Date:  2021-09-10       Impact factor: 5.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.